Keros Therapeutics, Inc. (KROS) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading KROS…

Keros Therapeutics, Inc. (KROS) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

Keros Therapeutics, Inc.

KROS · CIK 1664710

4 · Aug 20, 2026 · Chief Legal Officer Cho Esther sold 4,485 shares at $10.29/share ($46,151)

4

Chief Legal Officer Cho Esther sold 4,485 shares at $10.29/share ($46,151)

Filed: Aug 20, 2026
Period: Aug 18, 2026
Accession: 0002081460-26-000009
Filer: Keros Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/form4-08202026_040803.xml

xslF345X06/form4-08202026_040803.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4form4-08202026_040803.xml
Open SEC.gov